Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and...

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• Developing anticancer therapeutics with improved selectivity and reduced side effects is crucial.
• Intestinal flora disruption and emetic effects are common adverse events associated with current chemotherapies.

Purpose of the Study:

• To design and synthesize novel linear diarylheptanoids (LDHs).
• To evaluate the antibacterial, antiproliferative, and topoisomerase inhibitory activities of synthesized LDHs.

Main Methods:

• A series of LDHs were synthesized in a 7-step process.
• Compounds were tested for antibacterial activity against various bacterial strains.
• Antiproliferative activity was assessed against human breast cancer cell lines (T47D).
• Inhibition of topoisomerase-I and topoisomerase-IIα was evaluated.

Main Results:

• Synthesized LDHs demonstrated minimal antibacterial activity.
• Several compounds exhibited significant antiproliferative effects against T47D cells, with IC50 values as low as 0.09 μM for compound 6a.
• Compounds 7e and 7h showed moderate inhibition of topoisomerase-IIα (38.4% and 47.4%, respectively).

Conclusions:

• The synthesized LDHs show promise as anticancer agents, particularly against breast cancer.
• Reduced microbial activity suggests potential for enhanced selectivity and reduced side effects.
• Further investigation into these LDHs could lead to novel targeted cancer therapies.